Donald R. Kirsch

5.7k citations

36 papers · 5.1k indexed · 2 hit papers · h-index 21

Co-authors: N. Ronald Morris Berl R. Oakley Amanda M. Gillum Margaret Lai Richard B. Silverman Richard I. Morimoto Myra B. Kurtz Rosemarie Kelly
Topics: Amyotrophic Lateral Sclerosis Research (11 papers)Microbial Natural Products and Biosynthesis (10 papers)Fungal and yeast genetics research (8 papers)
Cited by: Infectious Diseases Molecular Biology Cell Biology
Journals: Molecular and Cellular Biology Analytical Biochemistry Biochemical and Biophysical Research Communications
Partner nations: United States Malaysia Germany

In The Last Decade

Donald R. Kirsch

35 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels

1980 3.0k citations Berl R. Oakley, Donald R. Kirsch et al. Analytical Biochemistry profile →
Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations

1984 1.1k citations Amanda M. Gillum, Donald R. Kirsch et al. profile →

Peers

Countries citing papers authored by Donald R. Kirsch

Since Specialization

Citations

This map shows the geographic impact of Donald R. Kirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Kirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Kirsch more than expected).

Fields of papers citing papers by Donald R. Kirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Kirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Kirsch. The network helps show where Donald R. Kirsch may publish in the future.

Co-authorship network of co-authors of Donald R. Kirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Kirsch. A scholar is included among the top collaborators of Donald R. Kirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Kirsch. Donald R. Kirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decision making in the pharmaceutical industry – A tale of three antibiotics 2020 ·International Journal of Pharmaceutics ·(unknown),Donald R. Kirsch	5
2	Proteasome Activation is a Mechanism for Pyrazolone Small Molecules Displaying Therapeutic Potential in Amyotrophic Lateral Sclerosis 2014 ·ACS Chemical Neuroscience ·Paul C. Trippier,Kevin T. Zhao,Susan G. Fox,Isaac T. Schiefer,(unknown),Jason M. Moran,Donald R. Kirsch,Richard I. Morimoto,Richard B. Silverman	45
3	Deuteration and fluorination of 1,3-bis(2-phenylethyl)pyrimidine-2,4,6(1H,3H,5H)-trione to improve its pharmacokinetic properties 2014 ·Bioorganic & Medicinal Chemistry Letters ·Guoyao Xia,(unknown),Richard I. Morimoto,Donald R. Kirsch,Richard B. Silverman	21
4	Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1 2012 ·Bioorganic & Medicinal Chemistry Letters ·Paul C. Trippier,(unknown),Donald R. Kirsch,Richard B. Silverman	13
5	Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells 2011 ·Bioorganic & Medicinal Chemistry ·Wei Zhang,(unknown),Anthony C. Arvanites,Richard I. Morimoto,Robert J. Ferrante,Donald R. Kirsch,Richard B. Silverman	26
6	Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis 2010 ·Amyotrophic Lateral Sclerosis ·(unknown),Anthony C. Arvanites,Jinho Kim,Robert J. Ferrante,Richard B. Silverman,Richard I. Morimoto,Donald R. Kirsch	35
7	Identification of a Novel Family of Nonclassic Yeast Phosphatidylinositol Transfer Proteins Whose Function Modulates Phospholipase D Activity and Sec14p-independent Cell Growth 2000 ·Molecular Biology of the Cell ·Xinmin Li,Sheri M. Routt,Zhigang Xie,Xiaoxia Cui,Min Fang,(unknown),Martin Bard,Donald R. Kirsch,Vytas A. Bankaitis	134
8	Cell Wall Active Antifungal Compounds Produced by the Marine Fungus Hypoxylon oceanicum LL-15G256. III. Biological Properties of 15G256.GAMMA.. 1998 ·The Journal of Antibiotics ·(unknown),(unknown),Patricia A. Bradford,(unknown),(unknown),(unknown),Donald R. Kirsch,Margaret Lai,(unknown),Ewald Sieverding,Sanford J. Silverman	23
9	Multiple Copies ofPBS2,MHP1 orLRE1 Produce Glucanase Resistance and Other Cell Wall Effects inSaccharomyces cerevisiae 1997 ·Yeast ·Margaret Lai,Sanford J. Silverman,(unknown),Donald R. Kirsch	30
10	V. Yeast sequencing reports. Identification of a gene encoding a new Ypt/Rab‐like monomeric G‐protein in Saccharomyces cerevisiae 1994 ·Yeast ·Margaret Lai,Martin Bard,Donald R. Kirsch	6
11	Development of improved cell-based assays and screens in Saccharomyces through the combination of molecular and classical genetics 1993 ·Current Opinion in Biotechnology ·Donald R. Kirsch	13
12	Lanomycin and glucolanomycin, antifungal agents produced by Pycnidiophora dispersa. I. Discovery, isolation and biological activity. 1992 ·The Journal of Antibiotics ·JOSEPH O''SULLIVAN,Douglas W. Phillipson,Donald R. Kirsch,Susan Fisher,Margaret Lai,WILLIAM H. TREJO	24
13	Dactylocyclines, novel tetracycline derivatives produced by a Dactylosporangium sp. I. Taxonomy, production, isolation and biological activity. 1992 ·The Journal of Antibiotics ·J. SCOTT WELLS,JOSEPH O''SULLIVAN,(unknown),HELEN A. AX,Adrienne A. Tymiak,Donald R. Kirsch,WILLIAM H. TREJO,Pacifico A. Principe	13
14	Cloning and characterization of the 2,3-oxidosqualene cyclase-coding gene of Candida albicans 1990 ·Gene ·Rosemarie Kelly,Susan M. Miller,Margaret Lai,Donald R. Kirsch	50
15	The Genetics of Candida 1990 ·Medical Entomology and Zoology ·Donald R. Kirsch,Rosemarie Kelly,Myra B. Kurtz	15
16	Lysobactin, a novel antibacterial agent produced by Lysobacter sp. I. Taxonomy, isolation and partial characterization. 1988 ·The Journal of Antibiotics ·JOSEPH O''SULLIVAN,(unknown),Adrienne A. Tymiak,Donald R. Kirsch,WILLIAM H. TREJO,Pacifico A. Principe	81
17	Neoberninamycin, a new antibiotic produced by Micrococcus luteus. 1988 ·The Journal of Antibiotics ·Joseph Biskupiak,E.A. Meyers,Amanda M. Gillum,LORETTA DEAN,WILLIAM H. TREJO,Donald R. Kirsch	20
18	Directed Mutagenesis in Candida albicans : One-Step Gene Disruption To Isolate ura3 Mutants 1987 ·Molecular and Cellular Biology ·Rosemarie Kelly,Susan M. Miller,Myra B. Kurtz,Donald R. Kirsch	52
19	Identification of macrotetrolide antibiotics in a screen to detect calcium channel blocking agents. 1987 ·The Journal of Antibiotics ·Joseph Biskupiak,JANICE H. JOHNSON,(unknown),(unknown),Anders Hedberg,(unknown),(unknown),Gabriella Geiger,Donald R. Kirsch	1
20	A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gelsbreakdown → 1980 ·Analytical Biochemistry ·Berl R. Oakley,Donald R. Kirsch,N. Ronald Morris	3024

About Donald R. Kirsch

Donald R. Kirsch is a scholar working on Pharmacology, Neurology and Genetics, having authored 36 papers that have together received 5.1k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (11 papers), Microbial Natural Products and Biosynthesis (10 papers) and Fungal and yeast genetics research (8 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Molecular Biology (2.9k citations) and Cell Biology (579 citations). Donald R. Kirsch has collaborated with scholars based in United States, Malaysia and Germany. Frequent co-authors include N. Ronald Morris, Berl R. Oakley, Amanda M. Gillum, Margaret Lai, Richard B. Silverman, Richard I. Morimoto, Myra B. Kurtz, Rosemarie Kelly, Martin Bard and Susan M. Miller. Their work appears in journals such as Molecular and Cellular Biology, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact